Folic Acid Deficiency



The prevalence of folate deficiency has decreased since many countries in the western hemisphere introduced a mandatory folic acid food fortification program starting in the late 1990s. People with excessive alcohol intake and malnutrition are still at high risk of folate deficiency. National Health and Nutrition Examination Survey (NHANES) data from 2003-2006 showed that certain groups, including women of childbearing age and non-Hispanic black women, are also at risk of folate deficiency, while some older adults are at risk of over-supplementation.[1]

Note the chart below.

View Image

Both folic acid and vitamin B-12 participate in the synthesis of DNA and RNA.

See 21 Hidden Clues to Diagnosing Nutritional Deficiencies, a Critical Images slideshow, to help identify clues to conditions associated with malnutrition.

Folic acid supplementation continues to be actively debated in the medical literature, with conflicting findings regarding its significance. While folate deficiency clearly predisposes to a number of health consequences, more recent studies raise concerns of toxicities and health consequences related to over-supplementation. Notable considerations regarding folate deficiency are as follows:

Folic acid supplementation clearly has significant public health implications. This article explores the mechanisms and manifestations behind folate deficiency, as well as its ramifications with regard to health and disease at large.


Folic acid is composed of a pterin ring connected to p-aminobenzoic acid (PABA) and conjugated with one or more glutamate residues. It is distributed widely in green leafy vegetables, citrus fruits, and animal products. Humans do not generate folate endogenously because they cannot synthesize PABA, nor can they conjugate the first glutamate.

Folates are present in natural foods and tissues as polyglutamates because these forms serve to keep the folates within cells. In plasma and urine, they are found as monoglutamates because this is the only form that can be transported across membranes. Enzymes in the lumen of the small intestine convert the polyglutamate form to the monoglutamate form of the folate, which is absorbed in the proximal jejunum via both active and passive transport.

Within the plasma, folate is present, mostly in the 5-methyltetrahydrofolate (5-methyl THFA) form, and is loosely associated with plasma albumin in circulation. The 5-methyl THFA enters the cell via a diverse range of folate transporters with differing affinities and mechanisms (ie, adenosine triphosphate [ATP]–dependent H+ cotransporter or anion exchanger). Once inside, 5-methyl THFA may be demethylated to THFA, the active form participating in folate-dependent enzymatic reactions. Cobalamin (B-12) is required in this conversion, and in its absence, folate is "trapped" as 5-methyl THFA.

From then on, folate no longer is able to participate in its metabolic pathways, and megaloblastic anemia results. Large doses of supplemental folate can bypass the folate trap, and megaloblastic anemia will not occur. However, the neurologic/psychiatric abnormalities associated with B-12 deficiency ensue progressively.

The biologically active form of folic acid is tetrahydrofolic acid (THFA), which is derived by the 2-step reduction of folate involving dihydrofolate reductase. THFA plays a key role in the transfer of 1-carbon units (such as methyl, methylene, and formyl groups) to the essential substrates involved in the synthesis of DNA, RNA, and proteins. More specifically, THFA is involved with the enzymatic reactions necessary to synthesis of purine, thymidine, and amino acid. Manifestations of folate deficiency thereafter, not surprisingly, would involve impairment of cell division, accumulation of possibly toxic metabolites such as homocysteine, and impairment of methylation reactions involved in the regulation of gene expression, thus increasing neoplastic risks.

A healthy individual has about 500-20,000 mcg of folate in body stores. Adults need to absorb approximately 400 mcg of folate per day in order to replenish the daily degradation and loss through urine and bile. Otherwise, signs and symptoms of deficiency can manifest after 4 months. The degree of folate absorption depends on its source. Approximately 50% of folate naturally occurring in food is bioavailable, whereas nearly 100% of folic acid supplements are absorbed when consumed fasting, and approximately 85% of folic acid supplementation is absorbed when consumed with food.[16]



United States

The current standard of practice is that serum folate levels less than 3 ng/mL and a red blood cell (RBC) folate level less than 140 ng/mL puts an individual at high risk of folate deficiency. The RBC folate level generally indicates folate stored in the body, whereas the serum folate level tends to reflect acute changes in folate intake.

Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000 indicate the prevalence of low serum folate concentrations (< 6.8 nmol/L) decreased from 16% before folic acid fortification to 0.5% after folic acid fortification.[17] In elderly persons, the prevalence of high serum folate concentrations (>45.3 nmol/L) increased from 7% before fortification to 38% after fortification.

Subsequent to the initial NHANES studies, subjects in the 2003-2006 cohort were asked about their daily supplement use in order to better quantify their total daily intake of folic acid.[1] It was discovered that 34.5% of the participants took supplements containing folic acid. Certain groups were over-supplementing, while other groups were still receiving inadequate doses. The participants ages 51-70 years took the highest doses of folate (combined food and supplement), with 5% exceeding the tolerable upper intake level. Two groups were most likely to consume inadequate folate (below the recommended dietary allowance): women of childbearing age (17-19%) and non-Hispanic black women (23%). The study authors concluded that efforts need to be made both to monitor for over-supplementation in certain groups and to target increased supplementation in the groups at risk for deficiency.

Several studies have demonstrated that high-dose folate may increase the risk of cancer.[10, 11, 12, 13, 14, 15, 18] Specifically, increased risks of prostate and colorectal cancer have been noted. However, despite experimental evidence suggesting increased risk of breast cancer progression,[12] a comparison of 2,491 breast cancer cases individually matched to 2,521 controls in the European Prospective Investigation into Cancer and Nutrition (EPIC) found that plasma levels of folate were not significantly associated with the overall risk of breast cancer.[19]

It is particularly concerning that the groups who are over-supplementing are among the highest risk for accelerating the growth of malignancy through overuse of folic acid, while many in the groups that are under-supplementing are women who could confer benefits of folic acid supplementation to a developing fetus. Clearly, folic acid supplementation continues to be an important primary care and public health issue.


Nearly every country in the western hemisphere has mandatory folic acid flour fortification, and most European countries have policies recommending folic acid supplementation prior to conception and for the first 3 months of pregnancy.[20]  Flour fortification with folic acid has been shown to result in significant improvements in folate status among women of reproductive age, in areas where folate deficiency is high.[21]

Casey et al examined the effects over 1 year of a free weekly iron-folic acid supplementation and deworming program in 52,000 Vietnamese women of childbearing age.[22] The investigators collected demographic data and blood and stool samples at baseline and at 3 and 12 months following the implementation of the program.

Findings included a mean Hb increase of 9.6 g/L (P< 0.001) and a reduction in the presence of anemia from 37.5% of the women at baseline to 19.3% at 12 months.[22] Iron deficiency was also reduced, from 22.8% at baseline to 9.3% by 12 months, as well as hookworm infection (76.2% at baseline to 23.0%) in the same period.


Hematologic manifestations

Folate deficiency can cause anemia. The presentation typically consists of macrocytosis and hypersegmented polymorphonuclear leukocytes (PMNs).[23] More detailed laboratory findings are discussed in the Workup section.

The anemia usually progresses over several months, and the patient typically does not express symptoms as such until the hematocrit level reaches less than 20%. At that point, symptoms such as weakness, fatigue, difficulty concentrating, irritability, headache, palpitations, and shortness of breath can occur. Furthermore, heart failure can develop in light of high-output cardiac compensation for the decreased tissue oxygenation. Angina pectoris may occur in predisposed individuals due to increased cardiac work demand. Tachycardia, postural hypotension, and lactic acidosis are other common findings. Less commonly, neutropenia and thrombocytopenia also will occur, although it usually will not be as severe as the anemia. In rare cases, the absolute neutrophil count can drop below 1000/mL and the platelet count below 50,000/mL.

Elevated serum homocysteine and atherosclerosis

Folate in the 5-methyl THFA form is a cosubstrate required by methionine synthase when it converts homocysteine to methionine. As a result, in the scenario of folate deficiency, homocysteine accumulates. Several recent clinical studies have indicated that mild-to-moderate hyperhomocystinemia is highly associated with atherosclerotic vascular disease such as coronary artery disease (CAD) and stroke. In this case, mild hyperhomocystinemia is defined as total plasma concentration of 15-25 mmol/L and moderate hyperhomocystinemia is defined as 26-50 mmol/L.

Genest et al found that a group of 170 men with premature coronary artery disease had a significantly higher average level of homocysteine (13.7 ± 6.4).[24] In another study, Coull et al found that among 99 patients with stroke or transient ischemic attacks (TIAs), about one third had elevated homocysteine.[25]

Elevated homocysteine levels might act as an atherogenic factor by converting a stable plaque into an unstable, potentially occlusive, lesion. Wang et al found that in patients with acute coronary syndromes, levels of homocysteine and monocyte chemoattractant protein-1 (MCP-1) were significantly higher.[26] MCP-1 is a chemokine characterized by the ability to induce migration and activation of monocytes and therefore may contribute to the pathogenesis of CAD. Homocysteine is believed to have atherogenic and prothrombotic properties via multiple mechanisms.

Bokhari et al found that among patients with CAD, the homocysteine level correlates independently with left ventricular systolic function.[27] The mechanism is unknown, but it may be due to a direct toxic effect of homocysteine on myocardial function separate from its effect on coronary atherosclerosis.

Although multiple observational studies have found a positive assocation between elevated plasma homocysteine levels and increased risk of atherosclerosis, randomized trials have not been able to demonstrate the utility of homocysteine-lowering therapy for outcomes other than stroke.[3, 4] In the Heart Outcomes Prevention Evaluation (HOPE) 2 trial, supplements combining folic acid and vitamins B-6 and B-12 did not reduce the risk of major cardiovascular events in patients with vascular disease.[28] Similarly, in the trial by Bonaa et al, treatment with B vitamins did not lower the risk of recurrent cardiovascular disease after acute myocardial infarction.[29]

While the risk of cardiac complications was not reduced with correction of hyperhomocysteinemia through supplementation, several studies have documented a reduction in stroke with supplementation. Two meta-analyses demonstrated a statistically significant reduction in stroke risk with folic acid supplementation at low doses (0.4-0.8 mg folic acid daily).[3, 4]

Pregnancy complications

Possible pregnancy complications secondary to maternal folate status may include spontaneous abortion, abruption placentae, congenital malformations (eg, neural tube defect), and severe language delay in the offspring. In a literature review, Ray et al examined 8 studies that demonstrated association between hyperhomocystinemia and placental abruption/infarction.[30] Folate deficiency also was a risk factor for placental abruption/infarction, although less statistically significant.[31]

Several observational and controlled trials have shown that neural tube defects can be reduced by 80% or more when folic acid supplementation is started before conception. In countries like the United States and Canada, the policy of widespread fortification of flour with folic acid has proved effective in reducing the number of neural tube defects.[32]

Although the exact mechanism is not understood, a relative folate shortage may exacerbate an underlying genetic predisposition to neural tube defects.

In a prospective observational study in Norway, where food is not fortified with folic acid, lack of supplementation with folic acid from 4 weeks before to 8 weeks after conception was associated with increased risk of severe language delay in the child at age 3 years.[33] No association between folic acid supplementation and gross motor skills was reported.

A more recent Norwegian prospective cohort study reexamined the maternal use of supplemental folic acid prior to and during pregnancy and demonstrated an association between child autism and lack of supplementation. There was no association between maternal folic acid supplementation and child Asperger syndrome or pervasive developmental disorder-not otherwise specified.[6]

Effects on carcinogens

Diminished folate status has historically been associated with enhanced carcinogenesis.[16] As recently as 2002, authors cited epidemiologic and laboratory data demonstrating that folic acid intake was inversely related to colon cancer risk.[34] The proposed mechanisms by which folic acid deficiency led to increased carcinogenesis included chromosomal breaks due to massive incorporation of uracil into human DNA.[35] and DNA strand breaks and hypomethylation within the P53 gene.[36]

More recently, a number of studies have demonstrated that folic acid supplementation can actually increase the risk of cancer.

A randomized controlled clinical trial from 1994-2004 examining the use of folic acid for the prevention of colorectal adenomas not only demonstrated that folic acid supplementation did not reduce colorectal adenoma risk, but suggested that this supplementation may increase the risk of colorectal neoplasia. This study demonstrated that folic acid supplementation increased the risk of having 3 or more adenomas.[15]

Prior to this study, authors had observed an increase in the rate of colorectal carcinomas in the United States and Canada in the 1990s, which was related temporally to the implementation of the mandatory folic acid supplementation government policies. They hypothesized that the addition of folic acid supplementation to American and Canadian diets was at least in part responsible for the rise in colorectal cancers.[14]

Similar conclusions were drawn by authors who studied a rise in colorectal cancers rates after a folic acid fortification program in Chile.[13] Folic acid supplementation has also been implicated in the development of prostate cancer,[11] and biochemical researchers have demonstrated that increasing folic acid levels led to dose-dependent down-regulation of tumor suppressor genes in breast cancer.[12]

In patients with inflammatory bowel disease, however, folic acid supplementation may reduce colorectal cancer risk. A systematic review and meta-analysis of 10 studies reporting on 4517 patients found an overall protective effect for folic acid supplementation on the development of colorectal cancer in this population, with a pooled hazard ratio of 0.58 (95% confidence interval, 0.37-0.80).[37]

The debate over the safety of widespread folic acid supplementation will certainly continue in the medical literature in the years to come. Care should be taken to ensure that individuals do not consume a greater-than-recommended dietary allowance of folic acid, and special consideration should be given to patients with history of colorectal adenomas and those at high risk for cancer.

Effects on cognitive function

Several studies have shown that an elevated homocysteine level correlates with cognitive decline. In Herbert's classic study in which a human subject (himself) was in induced folate deficiency from diet restriction, he noted that CNS effects, including irritability, forgetfulness, and progressive sleeplessness, appeared within 4-5 months. Interestingly, all CNS symptoms were reported to disappear within 48 hours after oral folate intake.[38]

Low folate and high homocysteine levels are a risk factor for cognitive decline in high-functioning older adults[39] and high homocysteine level is an independent predictor of cognitive impairment among long-term stay geriatric patients.[40]

Mechanistically speaking, current theory proposes that folate is essential for synthesis of S- adenosylmethionine, which is involved in numerous methylation reactions. This methylation process is central to the biochemical basis of proper neuropsychiatric functioning.

Despite the association of high homocysteine level and poor cognitive function, homocysteine-lowering therapy using supplementation with vitamins B-12 and B-6 was not associated with improved cognitive performance after two years in a double-blind, randomized trial in healthy older adults with elevated homocysteine levels.[41]

Sex- and Age-related Demographics

Pregnant women are at higher risk of developing folate deficiency because of increased requirements.

Certain elderly people also may be more susceptible to folate deficiency, as a result of their predisposition to mental status changes, social isolation, low intake of leafy vegetables and fruits, malnutrition, and comorbid medical conditions. The greatest risk appears to be among low-income populations and institutionalized elderly people; risk is lower in the free-living elderly population. In fact, analysis of 2003-2006 NHANES cohort showed that adults older than 50 years are the most likely to receive folic acid over-supplementation due to the consumption of both fortified foods and supplements containing folic acid.[1]

A study of 2922 children in a population-based cohort study revealed an association beween early high folic acid intakes and lower body weight and body mass index (BMI). This requires further investigation.[42]


In folate deficiency, the patient's history is important because it may reveal the underlying reason for the deficiency. Very often, a patient presents with a history of excessive alcohol intake with concurrent poor diet intake. Other patients may be pregnant or lactating; may take certain drugs, such as phenytoin, sulfonamides, or methotrexate; may have chronic hemolytic anemia; or may have underlying malabsorption.

Some patients complain of a sore tongue or pain upon swallowing. The tongue may appear swollen, beefy, red, or shiny, usually around the edges and tips initially. Angular stomatitis also may be observed. These oral lesions typically occur at the time when folate depletion is severe enough to cause megaloblastic anemia, although, occasionally, lesions may occur before the anemia.

Patients may present with gastrointestinal (GI) symptoms, such as nausea, vomiting, abdominal pain, and diarrhea, especially after meals. Anorexia also is common and, in combination with the above symptoms, may lead to marked weight loss. However, be aware that an underlying malabsorption disorder could be causing these symptoms, as well as folate depletion. The lack of folate itself may not be the culprit.

Neurologic presentations include cognitive impairment, dementia, and depression. These manifestations overlap with those of vitamin B-12 deficiency.{ref50)


Patients with folate deficiency may have darkening of the skin and mucous membranes, particularly at the dorsal surfaces of the fingers, toes, and creases of palms and soles. Distribution typically is patchy. Fortunately, the hyperpigmentation gradually should resolve after weeks or months of folate treatment. A modest temperature elevation (< 102°F) is common in patients who are folate deficient, despite the absence of any infection. Although the underlying mechanism is obscure, the temperature typically falls within 24-48 hours of vitamin treatment and returns to normal within a few days.


Folate deficiency can result from several possible causes, including inadequate ingestion, impaired absorption, impaired metabolism leading to inability to utilize folate that is absorbed, increased requirement, increased excretion, and increased destruction.

Inadequate ingestion of folate-containing foods

Poor nutrition is prevalent among people with alcoholism and patients with psychiatric morbidities, as well as elderly people (due to conditions such as ill-fitting dentures, physical disabilities, and social isolation). Because folates are destroyed by prolonged exposure to heat, people of certain cultures that involve traditionally cooking food in kettles of boiling water may be predisposed to folate deficiency. Moreover, for patients with renal and liver failure, anorexia and restriction of foods rich in protein, potassium, and phosphate contribute to decreased folate intake.

Impaired absorption

The limiting factor in folate absorption is its transport across the intestinal wall. Folate transport across the gut wall mainly is carrier mediated, saturable, substrate specific, pH dependent (optimal at low pH), sodium dependent, and susceptible to metabolic inhibitors. Passive, diffusional absorption also occurs, to a minor degree. With this in mind, a decreased absorptive area due to small bowel resection or mesenteric vascular insufficiency would decrease folate absorption.

Celiac disease and tropical sprue cause villous atrophy. The process of aging causes shorter and broader villi in 25% of the elderly population. Achlorhydria leads to elevation of gastric pH above the optimal level (ie, pH of 5) for folate absorption. Anticonvulsant drugs, such as Dilantin, interfere with mucosal conjugase, hence impairing folate absorption. Zinc deficiency also decreases folate absorption because zinc is required to activate mucosal conjugase. Bacterial overgrowth in blind loops, stricture formation, or jejunal diverticula likewise would decrease folate absorption.

Impaired metabolism, leading to inability to utilize absorbed folate

Antimetabolites that are structurally analogous to the folate molecule can competitively antagonize folate utilization. Methotrexate and trimethoprim both are folate antagonists that inhibit dihydrofolate reductase. Hypothyroidism has been known to decrease hepatic levels of dihydrofolate reductase as well as methylene THFA reductase. Furthermore, congenital deficiency involving the enzymes of folate metabolism also can show impaired folate utilization. People with alcoholism can have very active alcohol dehydrogenase that binds up folate and thus interferes with folate with folate utilization.

Increased requirement

Factors that increase the metabolic rate can increase the folic requirement. Infancy (a period of rapid growth), pregnancy (rapid fetal growth), lactation (uptake of folate into breast milk), malignancy (increased cell turnover), concurrent infection (immunoproliferative response), and chronic hemolytic anemia (increased hematopoiesis) all can result in an increased folate requirement.

Increased excretion/loss

Increased excretion of folate can occur subsequent to vitamin B-12 deficiency. During the course of vitamin B-12 deficiency, methylene THFA is known to accumulate in the serum, which is known as the folate trap phenomenon. In turn, large amounts of folate filter through the glomerulus, and urine excretion occurs. Another mechanism of excess excretion occurs in people with chronic alcoholism who can have increased excretion of folate into the bile. Patients undergoing hemodialysis also have been known to have excess folate loss during procedures.

Increased destruction

Superoxide, an active metabolite of ethanol metabolism, is known to inactivate folate by splitting the folate molecule in half between the C9 and N10 position. The relationship between cigarette smoking and low folate levels has been noted as possibly due to folate inactivation in exposed tissue.

Laboratory Studies

Serum folate and serum cobalamin  testing

As the initial test, ruling out cobalamin deficiency is very important because deficiency of folic acid and vitamin B-12 produce overlapping neurologic manifestations, and both cause megaloblastic anemia, but folate treatment will not improve neurologic abnormalities due to cobalamin deficiency.[43] The reference range for serum cobalamin is 200-900 pg/mL

The reference range of serum folate is 2.5-20 ng/mL. By statistical definition, 2%-5% of healthy individuals will have a serum folate level of less than 2.5 ng/mL; hence, the serum folate level cannot be used alone to establish the diagnosis of folate deficiency. Therefore, the serum folate test is definitive only when the level is greater than 5.0 ng/mL, which rules out folate deficiency. Otherwise, additional follow-up tests include serum homocysteine (reference range 5-16 mmol/L), which is elevated in vitamin B-12 and folate deficiency, and serum methylmalonic acid (reference range 70-270 mmol/L), which is elevated in vitamin B-12 deficiency only.

Red blood cell folate levels (reference range >140 ng/mL) tend to reflect long-term folate status rather than acute changes in folate that are reflected in serum folate levels, although many confounding factors, such as transfused red cells, can make this unreliable as a test for folate deficiency states.

Other than folate or cobalamin deficiency, the only other confounding causes for elevation of these compounds include renal failure, intravascular volume depletion, and some rare inborn errors of metabolism involving folate or cobalamin-dependent enzymes.


Bone marrow biopsy and aspirate may show a hypercellular bone marrow with a megaloblastic maturation of cells (see the slides below). This cannot be differentiated from changes observed with vitamin B-12 deficiency.

View Image

Histologically, the megaloblastosis caused by folic acid deficiency cannot be differentiated from that observed with vitamin B-12 deficiency.

View Image

Peripheral smear of blood in a patient with pernicious anemia. Macrocytes are observed and some of the red blood cells show ovalocytosis. A 6-lobed po....

View Image

Bone marrow aspirate from a patient with untreated pernicious anemia. Megaloblastic maturation of erythroid precursors is shown. Two megaloblasts occu....

Medical Care

Fruits, vegetables, and fortified foods constitute the primary dietary source of folic acid.

Recommended intakes as published by the Food and Nutrition Board (FNB) at the Institute of Medicine (IOM) of the National Academies[16] are as follows (RDA=recommended daily allowance, DFE=dietary folate equivalents, UL=tolerable upper level):

Because of variable absorption rates, an approximation of total folate intake in a day can be calculated as follows:

Grams of DFEs provided = grams of food folate + 1.7 × (grams of folic acid supplementation)


Consult a dietitian.


Diet should include fruits and vegetables.

Medication Summary

The goals of pharmacotherapy are to eliminate the vitamin deficiency, reduce morbidity, and prevent complications.

Folic acid (Folvite)

Clinical Context:  Folic acid is a cofactor for enzymes involved in the production of red blood cells. It replenishes depleted folate stores consumed during chronic hemolysis.

Class Summary

These agents are essential for normal DNA synthesis and for the formation of a number of coenzymes in many metabolic systems.

Further Outpatient Care

Treat the underlying disease or condition causing folic acid deficiency.


Patients whose folic acid deficiency is related to dietary factors should be counseled to include green vegetables and fruit in their diet.

Prophylactic treatment of pregnant patients and patients with chronic hemolytic anemias can prevent folic acid deficiency due to the increased requirement for folate in these conditions.


Note the following possible complications:

Patient Education

Educate patients regarding proper nutrition, including eating fruits and vegetables. Educate patients regarding the need to reduce alcohol ingestion. Discuss the need to take folic acid supplementation.

Medical/legal pitfalls

Failure to provide folic acid supplementation to pregnant females may lead to spontaneous abortion and fetal abnormalities, including neural tube defects and increased risk of severe language delay in the child.

Providing only folic acid supplementation to a patient who has cobalamin deficiency may lead to development of irreversible neuropathies.

No randomized clinical trial has proven the efficacy of lowering the homocysteine concentration to improve cognition or to lower the incidence of cardiovascular disease (CVD). Until new evidence is available, clinicians should not promise patients that folate supplementation will improve cognition or decrease cardiovascular risk.

What is folic acid deficiency?What is the pathophysiology of folic acid deficiency?What is the US prevalence of folic acid deficiency?What is the global prevalence of folic acid deficiency?What are the hematologic manifestations of folic acid deficiency?What are the cardiac complications of folic acid deficiency?What are the pregnancy complications of folic acid deficiency?What is the role of folic acid deficiency in carcinogenesis?How does folic acid deficiency affect cognitive functioning?Which patient populations are at increased risk for folic acid deficiency/Which clinical history findings are characteristic of folic acid deficiency?Which physical findings are characteristic of folic acid deficiency?What causes folic acid deficiency?What is the role of nutrition in the etiology of folic acid deficiency?What causes impaired absorption in folic acid deficiency?What is the role of impaired metabolism in the etiology of folic acid deficiency?What causes an increase in folic acid requirement?What causes increased excretion in folic acid deficiency?What causes increased destruction of folic acid in folic acid deficiency?What are the differential diagnoses for Folic Acid Deficiency?What is the role of lab testing in the workup of folic acid deficiency?What is the role of biopsy in the workup of folic acid deficiency?How is folic acid deficiency treated?Which specialist consultations are beneficial to patients with folic acid deficiency?Which dietary modifications are used in the treatment of folic acid deficiency?What is the role of medications in the treatment of folic acid deficiency?Which medications in the drug class Vitamins are used in the treatment of Folic Acid Deficiency?How is folic acid deficiency prevented?What are the possible complications of folic acid deficiency?What is included in patient education about folic acid deficiency?What are the adverse effects of untreated folic acid deficiency on pregnancy outcomes?What causes irreversible neuropathy in patients with folic acid deficiency?How is cognition improved in patients with folic acid deficiency?


Katherine Coffey-Vega, MD, Fellow, Department of Internal Medicine, Division of Geriatrics, Virginia Commonwealth University School of Medicine

Disclosure: Nothing to disclose.


Angela Gentili, MD, Director of Geriatric Medicine Fellowship Program, Professor of Internal Medicine, Division of Geriatric Medicine, Virginia Commonwealth University Health System and McGuire Veterans Affairs Medical Center, Richmond, VA

Disclosure: Nothing to disclose.

David Kuan-Hua Chen, MD, Consulting Staff, Department of Neurology, Michael E DeBakey Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Muhammad Vohra, MD,

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Marcel E Conrad, MD, Distinguished Professor of Medicine (Retired), University of South Alabama College of Medicine

Disclosure: Partner received none from No financial interests for none.

Chief Editor

Emmanuel C Besa, MD, Professor Emeritus, Department of Medicine, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University

Disclosure: Nothing to disclose.

Additional Contributors

Pradyumna D Phatak, MBBS, MD, Chair, Division of Hematology and Medical Oncology, Rochester General Hospital; Clinical Professor of Oncology, Roswell Park Cancer Institute

Disclosure: Received honoraria from Novartis for speaking and teaching.


The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor Ahmed Mosalem, MD, to the development and writing of this article.

The authors and editors of Medscape Reference also gratefully acknowledge the contributions of previous coauthors Subir Vij, MD, MPH and Waleed Siddiqi, MD to the development and writing of this article.


  1. Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr. 2010 Jan. 91(1):231-7. [View Abstract]
  2. Varela-Moreiras G, Murphy MM, Scott JM. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009 May. 67 Suppl 1:S69-72. [View Abstract]
  3. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr. 2012 Aug. 31(4):448-54. [View Abstract]
  4. Huo Y, Qin X, Wang J, Sun N, Zeng Q, Xu X. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis. Int J Clin Pract. 2012 Jun. 66(6):544-51. [View Abstract]
  5. Hankey GJ. B vitamins for stroke prevention. Stroke Vasc Neurol. 2018 Jun. 3 (2):51-58. [View Abstract]
  6. Surén P, Roth C, Bresnahan M, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013 Feb 13. 309(6):570-7. [View Abstract]
  7. Correa A, Gilboa SM, Botto LD, Moore CA, Hobbs CA, Cleves MA. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol. 2012 Mar. 206(3):218.e1-13. [View Abstract]
  8. Cantarella CD, Ragusa D, Giammanco M, Tosi S. Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature. Genes Nutr. 2017. 12:14. [View Abstract]
  9. Enderami A, Zarghami M, Darvishi-Khezri H. The effects and potential mechanisms of folic acid on cognitive function: a comprehensive review. Neurol Sci. 2018 Jun 23. [View Abstract]
  10. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009 Nov 18. 302(19):2119-26. [View Abstract]
  11. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009 Mar 18. 101(6):432-5. [View Abstract]
  12. Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Fabianowska-Majewska K. Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun. 2013 Jan 11. 430(2):623-8. [View Abstract]
  13. Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol. 2009 Apr. 21(4):436-9. [View Abstract]
  14. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007 Jul. 16(7):1325-9. [View Abstract]
  15. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 6. 297(21):2351-9. [View Abstract]
  16. Institute of Medicine. Food and Nutrition Board. Dietary reference intakes: thiamine, riboflavin, niacin, vitamin B6, folate, vitamin b12, pantothenic acid, biotin and choline. Washington DC: National Academy Press; 1998.
  17. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005 Aug. 82(2):442-50. [View Abstract]
  18. Pieroth R, Paver S, Day S, Lammersfeld C. Folate and Its Impact on Cancer Risk. Curr Nutr Rep. 2018 Sep. 7 (3):70-84. [View Abstract]
  19. Matejcic M, de Batlle J, Ricci C, Biessy C, Perrier F, et al. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort. Int J Cancer. 2017 Mar 15. 140 (6):1246-1259. [View Abstract]
  20. European Surveillance of Congenital Anomalies. Folic Acid. Available at Accessed: September 14, 2018.
  21. Noor RA, Abioye AI, Ulenga N, Msham S, Kaishozi G, Gunaratna NS, et al. Large -scale wheat flour folic acid fortification program increases plasma folate levels among women of reproductive age in urban Tanzania. PLoS One. 2017. 12 (8):e0182099. [View Abstract]
  22. Casey GJ, Phuc TQ, Macgregor L, et al. A free weekly iron-folic acid supplementation and regular deworming program is associated with improved hemoglobin and iron status indicators in Vietnamese women. BMC Public Health. 2009 Jul 24. 9:261. [View Abstract]
  23. Chang JY, Wang YP, Wu YC, Cheng SJ, Chen HM, Sun A. Hematinic deficiencies and anemia statuses in oral mucosal disease patients with folic acid deficiency. J Formos Med Assoc. 2015 Sep. 114 (9):806-12. [View Abstract]
  24. Genest JJ Jr, McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990 Nov. 16(5):1114-9. [View Abstract]
  25. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 1990 Apr. 21(4):572-6. [View Abstract]
  26. Wang G, Mao JM, Wang X, Zhang FC. Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes. Chin Med J (Engl). 2004 Nov. 117(11):1650-4.
  27. Bokhari SW, Bokhari ZW, Zell JA, Lee DW, Faxon DP. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients. Coron Artery Dis. 2005 May. 16(3):153-61. [View Abstract]
  28. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006 Apr 13. 354(15):1567-77. [View Abstract]
  29. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13. 354(15):1578-88. [View Abstract]
  30. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta. 1999 Sep. 20(7):519-29. [View Abstract]
  31. Wolff T, Witkop CT, Miller T, Syed SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 May 5. 150(9):632-9. [View Abstract]
  32. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001 Jun 20. 285(23):2981-6. [View Abstract]
  33. Roth C, Magnus P, Schjolberg S, et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA. 2011 Oct 12. 306(14):1566-73. [View Abstract]
  34. Gatof D, Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin North Am. 2002 Jun. 31(2):587-623, xi. [View Abstract]
  35. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997 Apr 1. 94(7):3290-5. [View Abstract]
  36. Kim YI, Pogribny IP, Basnakian AG, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr. 1997 Jan. 65(1):46-52. [View Abstract]
  37. Burr NE, Hull MA, Subramanian V. Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2017 Mar. 51 (3):247-253. [View Abstract]
  38. Nutrition classics. Transactions of the Association of American Physicians, volume 75, 1962, pages 307-320. Experimental nutritional folate deficiency in man. by Victor Herbert. Nutr Rev. 1982 Aug. 40 (8):246-8. [View Abstract]
  39. Kado DM, Karlamangla AS, Huang MH, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med. 2005 Feb. 118(2):161-7. [View Abstract]
  40. Adunsky A, Arinzon Z, Fidelman Z, Krasniansky I, Arad M, Gepstein R. Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study. Arch Gerontol Geriatr. 2005 Mar-Apr. 40(2):129-38. [View Abstract]
  41. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006 Jun 29. 354(26):2764-72. [View Abstract]
  42. Braun KV, Voortman T, Kiefte-de Jong JC, Jaddoe VW, Hofman A, Franco OH, et al. Dietary Intakes of Folic Acid and Methionine in Early Childhood Are Associated with Body Composition at School Age. J Nutr. 2015 Sep. 145 (9):2123-9. [View Abstract]
  43. Reynolds EH. The neurology of folic acid deficiency. Handb Clin Neurol. 2014. 120:927-43. [View Abstract]
  44. Shiraishi M, Haruna M, Matsuzaki M, et al. Association Between Oxidized LDL and Folate During Pregnancy. Biol Res Nurs. 2013 Apr. 15(2):213-8. [View Abstract]

Both folic acid and vitamin B-12 participate in the synthesis of DNA and RNA.

Histologically, the megaloblastosis caused by folic acid deficiency cannot be differentiated from that observed with vitamin B-12 deficiency.

Peripheral smear of blood in a patient with pernicious anemia. Macrocytes are observed and some of the red blood cells show ovalocytosis. A 6-lobed polymorphonuclear leucocyte is present.

Bone marrow aspirate from a patient with untreated pernicious anemia. Megaloblastic maturation of erythroid precursors is shown. Two megaloblasts occupy the center of the slide with a megaloblastic normoblast above.

The chemical structure of folic acid and amethopterin (methotrexate), a folic acid antagonist, shows the similarity of structure.

The transformation of formiminoglutamic acid to glutamic acid is dependent upon both vitamin B-12 and tetrahydrofolate. In contrast, the transformation of homocysteine to methionine is a vitamin B-12–dependent reaction.

Both folic acid and vitamin B-12 participate in the synthesis of DNA and RNA.

Histologically, the megaloblastosis caused by folic acid deficiency cannot be differentiated from that observed with vitamin B-12 deficiency.

Peripheral smear of blood in a patient with pernicious anemia. Macrocytes are observed and some of the red blood cells show ovalocytosis. A 6-lobed polymorphonuclear leucocyte is present.

Bone marrow aspirate from a patient with untreated pernicious anemia. Megaloblastic maturation of erythroid precursors is shown. Two megaloblasts occupy the center of the slide with a megaloblastic normoblast above.